Monday, 05 March 2012 16:07

Bio-G Whitepaper: Biomanufacturing Debottlenecking and Process Optimization

Optimizing biomanufacturing is particularly challenging because of variability and complexity associated with the sharing of finite and interdependent resources. Traditional approaches, like polling subject matter experts on the manufacturing floor or analyzing resource utilization rates, simply do not work. Worse still, the answers these approaches provide are often costly and can actually be detrimental to run rates and other critical KPIs.

What's needed is a fundamentally different approach. This approach, described in detail in this whitepaper, outlines how sequential debottlenecking based on discrete event simulation, combined with sophisticated "design of experiments" tuning, is the best way to truly maximize throughput. And, because of process variability and drift, we describe the importance of running this optimization process on a frequent basis. Biomanufacturing processes are dynamic and complex, and the methodology described in this whitepaper will help you get the highest possible run-rates and return on investment from your manufacturing facilities.

Please register to download this whitepaper here.
 

Read 1261 times

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...

Podcasts